Inpatient care for urological patients in a pandemic of the coronavirus disease infection COVID-19


DOI: 10.29188/2222-8543-2020-12-1-4-11

Malhasyan V.A., Kasyan G.R., Hodyreva L.A., Kolontarev K.B., Govorov A.V., Vasil'ev A.O., Pushkar' D.Yu.
№1 2020

Objective. Since the firstcases of Coronavirus Disease were detected in Wuhan (Hubei Province, China) in December 2019, the spread distribution of COVID-19 has expanded so much that the World Health Organization declared COVID-19 a pandemic.

Materials. Currently, cases of infection are recorded in almost all countries of the world, there is a daily increase in the number of infected by an average of 100 000, and the death toll by average estimates is over 115 000. At present time, the «leading» position in the number of cases of COVID-19 detected belongs to the United States, in which overthe entire observation period, more than 500 000 cases were recorded. In Spain, Italy, France and Germany the total number of cases exceeded 526 000 people in less than a month. The rapid growth in the number of newly diagnosed cases of COVID-19 dictates the need for search for optimal ways of providing medical care.

Clinical practice and results. This article discusses the options for providing inpatient care to urological patients in a pandemic of the coronary viral infection COVID-19. Clinical practice is described and a list of urological diseases is presented, the surgical treatment of which is possible in a pandemic. Intraoperative measures have been developed to reduce the risk of viralcontamination during laparoscopic and robot-assisted operations. The routing and scope of work with patients suffering from acute urological diseases are described in detail: renal colic, acute obstructive pyelonephritis, macrohematuria, acute urinary retention.

Conclusion. The principles of the organization of work of the urological department and precautions in identifying patients with COVID19 have been developed.

Conflict of interest. The authors declare no conflict of interest.

Read in the source